Yasir Ali

Yasir Ali

Auto-generated profile, based on publicly available information

Yasir Ali


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2026 in Chaos, Solitons & Fractals
Verified
Journal Article
Open access
SISana Irshad
Sana Irshad
YAYasir Ali
Yasir Ali
Yilun ShangYilun Shang
Yilun Shang

29 October 2026 in ChemistryOpen
Verified
Journal Article
Open access
ZBZainab Bibi
Zainab Bibi
JAJabbar Ali
Jabbar Ali
SISana Irshad
Sana Irshad
MGMuhammad Saad Ghafar
Muhammad Saad Ghafar
YAYasir Ali
Yasir Ali
Yilun ShangYilun Shang
Yilun Shang
Machine learning is increasingly used to explore structure–property relationships in dendrimer‐drug systems; however, its integration with topology‐based structural compatibility analysis remains limited. This study presents a learning‐driven framework to evaluate the topology‐based structural compatibility of perylene diimide core dendrimers with antiviral, antioxidant, and imaging agents. Within a quantitative structure–property relationship framework, linear regression, Gaussian process regression (GPR), and artificial neural networks are employed to identify dominant graph‐theoretic topological indices and to capture linear and nonlinear structure–property relationships. These insights are combined with a structure‐based compatibility analysis that ranks dendrimer generations without altering drug identity or ordering. Generation‐wise compatibility is computed using standardized Euclidean distance after global normalization, and ranking stability is assessed through monotonic and magnitude analysis. Results show class‐dependent descriptor relevance, with GPR achieving test‐set R 2 values above 0.94 for molecular weight, exact mass, monoisotopic mass, and heavy atom count. The generation‐wise compatibility analysis further reveals distinct topology‐based structural compatibility patterns across the investigated drug classes, highlighting the value of integrating machine learning with graph‐theoretic analysis for rational nanocarrier design and the computational assessment of potential encapsulation suitability.